| **SEGMENT RESULTS (Reportable Segment Information ) (Details) - USD ($) $ in Millions**                 | 3 Months Ended | 9 Months Ended |
|---------------------------------------------------------------------------------------------------------|----------------|----------------|
||
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Net sales                                                                                               | $ 1,915        | $ 1,809        | $ 5,370 | $ 5,306 |
| Earnings (losses) before income taxes                                                                   | (245)          | 200            | 1 | 478 |
| Total restructuring and related implementation costs                                                    | 21             |           | 44 |   |
| Goodwill, trademark and other asset impairments                                                         | 445            | 0              | 445 | 0 |
| VMS reporting unit                                                                                      |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Goodwill, trademark and other asset impairments                                                         | 433            |           | 433 |   |
| International reporting unit                                                                            |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Goodwill, trademark and other asset impairments                                                         | $ 12           |           | $ 12 |   |
| Restructuring and Related Costs | Product Concentration Risk                                            |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Concentration percentage                                                                                | 100.00%        |           | 100.00% |   |
| Operating Segments | Health and Wellness                                                                |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Net sales                                                                                               | $ 707          | 662            | $ 2,054 | 2,055 |
| Earnings (losses) before income taxes                                                                   | $ (290)        | 84             | $ (72) | 245 |
| Operating Segments | Health and Wellness | Restructuring and Related Costs | Product Concentration Risk |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Concentration percentage                                                                                | 7.00%          |           | 6.00% |   |
| Operating Segments | Household                                                                          |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Net sales                                                                                               | $ 550          | 539            | $ 1,435 | 1,404 |
| Earnings (losses) before income taxes                                                                   | $ 99           | 92             | $ 165 | 138 |
| Operating Segments | Household | Restructuring and Related Costs | Product Concentration Risk           |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Concentration percentage                                                                                | 4.00%          |           | 2.00% |   |
| Operating Segments | Lifestyle                                                                          |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Net sales                                                                                               | $ 353          | 306            | $ 1,005 | 961 |
| Earnings (losses) before income taxes                                                                   | $ 83           | 66             | $ 217 | 239 |
| Operating Segments | Lifestyle | Restructuring and Related Costs | Product Concentration Risk           |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Concentration percentage                                                                                | 2.00%          |           | 3.00% |   |
| Operating Segments | International                                                                      |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Net sales                                                                                               | $ 305          | 302            | $ 876 | 886 |
| Earnings (losses) before income taxes                                                                   | $ 15           | 31             | $ 62 | 80 |
| Operating Segments | International | Restructuring and Related Costs | Product Concentration Risk       |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Concentration percentage                                                                                | 21.00%         |           | 19.00% |   |
| Corporate                                                                                               |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Earnings (losses) before income taxes                                                                   | $ (152)        | $ (73)         | $ (371) | $ (224) |
| Corporate | Restructuring and Related Costs | Product Concentration Risk                                |           |           |   |   |
| **Segment Reporting Information [Line Items]**                                                          |           |           |   |   |
| Concentration percentage                                                                                | 66.00%         |           | 70.00% |   |

| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228
+ Details**Name:**us-gaap_AssetImpairmentCharges**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details**Name:**us-gaap_ConcentrationRiskPercentage1**Namespace Prefix:**us-gaap_**Data Type:**dtr-types:percentItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 20 -Section 25 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(10)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(8)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884Reference 9: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(15)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
+ Details**Name:**us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(1) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(1)) -URI https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(d)) -URI https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747
+ Details**Name:**us-gaap_RestructuringAndRelatedCostIncurredCost**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856
+ Details**Name:**us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details**Name:**us-gaap_SegmentReportingInformationLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                       |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ReportingUnitAxis=clx_VitaminsMineralsAndSupplementsReportingUnitMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ReportingUnitAxis=clx_InternationalReportingUnitMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                         |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                     |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                    |
|------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |